229 related articles for article (PubMed ID: 38464332)
1. Acute opioid overdose in pediatric patients.
Sandelich S; Hooley G; Hsu G; Rose E; Ruttan T; Schwarz ES; Simon E; Sulton C; Wall J; Dietrich AM
J Am Coll Emerg Physicians Open; 2024 Apr; 5(2):e13134. PubMed ID: 38464332
[TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
3. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
Kohan LR; Elmofty D; Pena I; Liao C
J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
[TBL] [Abstract][Full Text] [Related]
4. Pediatric postoperative opioid prescribing and the opioid crisis.
Harbaugh CM; Gadepalli SK
Curr Opin Pediatr; 2019 Jun; 31(3):378-385. PubMed ID: 31090580
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental Overdose.
Skoy E; Frenzel O; Eukel H; Lothspeich E; Steig J; Strand M; Werremeyer A
Prev Chronic Dis; 2022 Jul; 19():E41. PubMed ID: 35834737
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids.
Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D
Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098
[TBL] [Abstract][Full Text] [Related]
7. Unintentional overdoses: understanding the fentanyl landscape and reducing harm.
Bell LA; Hadland SE
Curr Opin Pediatr; 2023 Aug; 35(4):408-414. PubMed ID: 36974444
[TBL] [Abstract][Full Text] [Related]
8. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
[TBL] [Abstract][Full Text] [Related]
9. Distribution of intranasal naloxone to potential opioid overdose bystanders in Sweden: effects on overdose mortality in a full region-wide study.
Håkansson A; Alanko Blomé M; Isendahl P; Landgren M; Malmqvist U; Troberg K
BMJ Open; 2024 Jan; 14(1):e074152. PubMed ID: 38171623
[TBL] [Abstract][Full Text] [Related]
10. Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy-Observational study.
Takeda MY; Katzman JG; Dole E; Bennett MH; Alchbli A; Duhigg D; Yonas H
Subst Abus; 2016; 37(4):591-596. PubMed ID: 27093555
[TBL] [Abstract][Full Text] [Related]
11. Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose.
Skoy E; Werremeyer A; Steig J; Eukel H; Frenzel O; Strand M
Subst Abus; 2021; 42(4):672-677. PubMed ID: 33044896
[No Abstract] [Full Text] [Related]
12. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
[TBL] [Abstract][Full Text] [Related]
13. Opioid overdose prevention education for medical students: Adopting harm reduction into mandatory clerkship curricula.
Oldfield BJ; Tetrault JM; Wilkins KM; Edelman EJ; Capurso NA
Subst Abus; 2020; 41(1):29-34. PubMed ID: 31211657
[No Abstract] [Full Text] [Related]
14. Risk factors for severe respiratory depression from prescription opioid overdose.
Fox LM; Hoffman RS; Vlahov D; Manini AF
Addiction; 2018 Jan; 113(1):59-66. PubMed ID: 28646524
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada.
Allen ST; O'Rourke A; Johnson JA; Cheatom C; Zhang Y; Delise B; Watkins K; Reich K; Reich R; Lockett C
Ann Med; 2022 Dec; 54(1):2692-2700. PubMed ID: 36168975
[TBL] [Abstract][Full Text] [Related]
16. U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts.
Bennett AS; Guarino H; Britton PC; O'Brien-Mazza D; Cook SH; Taveras F; Cortez J; Elliott L
Ann Med; 2022 Dec; 54(1):1826-1838. PubMed ID: 35792749
[TBL] [Abstract][Full Text] [Related]
17. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.
Winhusen T; Walley A; Fanucchi LC; Hunt T; Lyons M; Lofwall M; Brown JL; Freeman PR; Nunes E; Beers D; Saitz R; Stambaugh L; Oga EA; Herron N; Baker T; Cook CD; Roberts MF; Alford DP; Starrels JL; Chandler RK
Drug Alcohol Depend; 2020 Dec; 217():108325. PubMed ID: 33091842
[TBL] [Abstract][Full Text] [Related]
18. Preventing deaths from rising opioid overdose in the US - the promise of naloxone antidote in community-based naloxone take-home programs.
Straus MM; Ghitza UE; Tai B
Subst Abuse Rehabil; 2013 Sep; 2013(4):65-72. PubMed ID: 24273417
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
